ATE535813T1 - Reduzierte kreuzreaktivität mit hydrophoben arzneistoffanalyt-stoffwechselprodukten zeigende immuntestverfahren - Google Patents

Reduzierte kreuzreaktivität mit hydrophoben arzneistoffanalyt-stoffwechselprodukten zeigende immuntestverfahren

Info

Publication number
ATE535813T1
ATE535813T1 AT08769692T AT08769692T ATE535813T1 AT E535813 T1 ATE535813 T1 AT E535813T1 AT 08769692 T AT08769692 T AT 08769692T AT 08769692 T AT08769692 T AT 08769692T AT E535813 T1 ATE535813 T1 AT E535813T1
Authority
AT
Austria
Prior art keywords
reactivity
hydrophobic drug
reduced cross
testing procedures
showing reduced
Prior art date
Application number
AT08769692T
Other languages
English (en)
Inventor
Elaine Brate
David Finley
Shelley Holets-Mccormack
David Pacenti
Ryan Piktel
Michelle Shields
Thomas Spring
Philip Wang
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE535813T1 publication Critical patent/ATE535813T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9493—Immunosupressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT08769692T 2007-05-24 2008-05-23 Reduzierte kreuzreaktivität mit hydrophoben arzneistoffanalyt-stoffwechselprodukten zeigende immuntestverfahren ATE535813T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94006207P 2007-05-24 2007-05-24
PCT/US2008/064688 WO2008147982A1 (en) 2007-05-24 2008-05-23 Immunoassays exhibiting reduced cross-reactivity with hydrophobic drug analyte metabolites

Publications (1)

Publication Number Publication Date
ATE535813T1 true ATE535813T1 (de) 2011-12-15

Family

ID=39708486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08769692T ATE535813T1 (de) 2007-05-24 2008-05-23 Reduzierte kreuzreaktivität mit hydrophoben arzneistoffanalyt-stoffwechselprodukten zeigende immuntestverfahren

Country Status (7)

Country Link
US (1) US8288111B2 (de)
EP (1) EP2174137B1 (de)
JP (1) JP5174898B2 (de)
AT (1) ATE535813T1 (de)
CA (1) CA2685830C (de)
ES (1) ES2377167T3 (de)
WO (1) WO2008147982A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5174898B2 (ja) 2007-05-24 2013-04-03 アボット・ラボラトリーズ 疎水性薬物検体代謝産物との交差反応性が低下している免疫アッセイ
US7910378B2 (en) * 2007-12-14 2011-03-22 Siemens Healthcare Diagnostics Inc. Methods for detection of hydrophobic drugs
US8652788B2 (en) * 2009-12-02 2014-02-18 Abbott Laboratories Assay for diagnosis of cardiac myocyte damage
JP5798720B2 (ja) * 2010-03-30 2015-10-21 積水メディカル株式会社 ヒトｃ反応性タンパク質（ｃｒｐ）測定用イムノクロマト試薬
US8409807B2 (en) 2010-10-22 2013-04-02 T2 Biosystems, Inc. NMR systems and methods for the rapid detection of analytes
CA3155334A1 (en) 2010-10-22 2012-04-26 T2 Biosystems, Inc. NMR SYSTEMS AND METHODS FOR RAPID ANALYTE DETECTION
US8563298B2 (en) 2010-10-22 2013-10-22 T2 Biosystems, Inc. NMR systems and methods for the rapid detection of analytes
JP5938471B2 (ja) 2011-05-27 2016-06-22 アボット ポイント オブ ケア インコーポレイテッド Ｔｓｈ免疫アッセイ及び内在性夾雑物の存在下におけるｔｓｈ免疫アッセイを限定的な洗浄フォーマットで実施するための方法
US9199234B2 (en) 2011-05-27 2015-12-01 Abbott Point Of Care Inc. TSH antibodies for point-of-care immunoassay formats
WO2012166200A1 (en) 2011-05-27 2012-12-06 Abbott Point Of Care Inc. Tsh immunoassays employing scavenging reagents for cross-reacting endocrine glycoprotein hormone analogues
US9562271B2 (en) 2012-04-20 2017-02-07 T2 Biosystems, Inc. Compositions and methods for detection of Candida species
WO2014087802A1 (ja) * 2012-12-05 2014-06-12 コニカミノルタ株式会社 表面プラズモン励起増強蛍光分光法（ｓｐｆｓ）を用いた免疫測定法における夾雑物由来の非特異的シグナルの抑制方法
EP3405479A4 (de) 2016-01-21 2019-08-21 T2 Biosystems, Inc. Nmr-verfahren und -systeme zur schnellen detektion von bakterien
KR102448428B1 (ko) 2017-01-27 2022-09-30 가부시키가이샤 가네카 내배엽계 세포 집단, 및 다능성 세포로부터 3배엽 중 어느 하나의 세포 집단을 제조하는 방법
JP7233669B2 (ja) * 2017-05-22 2023-03-07 国立大学法人金沢大学 双性イオンを含む難溶性物質溶解剤
CN111512154B (zh) 2017-12-25 2022-05-27 富士瑞必欧株式会社 针对大环内酯类免疫抑制剂的血液检测方法
CN112014555B (zh) * 2020-08-31 2023-08-08 武汉生之源生物科技股份有限公司 一种酶标抗体缓冲液、试剂r1和肌酸激酶同工酶测定试剂盒
WO2024137034A1 (en) * 2022-12-21 2024-06-27 Siemens Healthcare Diagnostics Inc. Cyclosporine-acridinium esters and methods of production and use thereof

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169773A (en) * 1984-10-04 1992-12-08 Sandoz Ltd. Monoclonal antibodies to cyclosporins
DE3587342T2 (de) 1984-10-04 1993-12-02 Sandoz Ag Cyclosporine.
US5427960A (en) * 1987-03-27 1995-06-27 Abbott Laboratories Fluorescence polarization assay for cyclosporin A and metabolites and related immunogens and antibodies
US5239057A (en) * 1987-03-27 1993-08-24 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
EP0283801A3 (de) 1987-03-27 1990-05-30 Abbott Laboratories Fluoreszenz-Polarisations-Test für Cyclosporin A und Metaboliten und verwandte Immunogene und Antikörper
US5006309A (en) * 1988-04-22 1991-04-09 Abbott Laboratories Immunoassay device with liquid transfer between wells by washing
US5089424A (en) * 1988-06-14 1992-02-18 Abbott Laboratories Method and apparatus for heterogeneous chemiluminescence assay
US5063081A (en) * 1988-11-14 1991-11-05 I-Stat Corporation Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor
ES2084069T3 (es) * 1990-08-15 1996-05-01 Abbott Lab Reactivos de inmunoensayo y metodo para la determinacion de ciclosporina.
CA2048302A1 (en) 1990-08-15 1992-02-16 Victoria P. Meucci Solubilization reagent for biological test samples
US5135875A (en) * 1990-08-15 1992-08-04 Abbott Laboratories Protein precipitation reagent
DE69133095T2 (de) * 1990-11-20 2003-03-27 Dade Behring Marburg Gmbh Cyclosporin-Immunoassay
US5506114A (en) * 1992-02-07 1996-04-09 Osborn Laboratories Methods and kits for detecting the presence or concentration of biological analytes
US6664114B1 (en) * 1992-08-03 2003-12-16 Sapidyne Instruments, Inc. Solid phase assay for detection of ligands
US6777198B2 (en) * 2000-10-11 2004-08-17 Pharmacia Diagnostics Ab Assay method and kit therefor
US7419821B2 (en) * 2002-03-05 2008-09-02 I-Stat Corporation Apparatus and methods for analyte measurement and immunoassay
US20040018577A1 (en) * 2002-07-29 2004-01-29 Emerson Campbell John Lewis Multiple hybrid immunoassay
US7682833B2 (en) * 2003-09-10 2010-03-23 Abbott Point Of Care Inc. Immunoassay device with improved sample closure
US7723099B2 (en) * 2003-09-10 2010-05-25 Abbott Point Of Care Inc. Immunoassay device with immuno-reference electrode
CA2602732A1 (en) * 2005-04-06 2006-10-12 Abbott Laboratories Methods to measure immunosuppressive tacrolimus, sirolimus, and cyclosporin a complexes in a blood sample
US7575875B2 (en) * 2005-10-13 2009-08-18 Abbott Laboratories, Inc. Method of tacrolimus extraction and quantification using aqueous detergents
US7256008B2 (en) * 2006-01-06 2007-08-14 Abbott Laboratories Determination of concentration of FK778 by competitive immunoassay
US8022188B2 (en) * 2006-04-24 2011-09-20 Abbott Laboratories Immunosuppressant binding antibodies and methods of obtaining and using same
US7883855B2 (en) * 2006-07-21 2011-02-08 Abbott Laboratories Immunosuppressant drug extraction reagent for immunoassays
EP2118656B1 (de) 2006-12-29 2012-08-29 Abbott Laboratories Verbessertes testverfahren für immunsuppressiva
CA2673314C (en) 2006-12-29 2014-03-11 Abbott Laboratories Non-denaturing lysis reagent for use with capture-in-solution immunoassay
ES2405364T3 (es) 2006-12-29 2013-05-30 Abbott Laboratories Ensayo diagnóstico para la detección de una molécula o fármaco en sangre entera
US7914999B2 (en) * 2006-12-29 2011-03-29 Abbott Laboratories Non-denaturing lysis reagent
JP5174898B2 (ja) 2007-05-24 2013-04-03 アボット・ラボラトリーズ 疎水性薬物検体代謝産物との交差反応性が低下している免疫アッセイ

Also Published As

Publication number Publication date
EP2174137B1 (de) 2011-11-30
JP2010528295A (ja) 2010-08-19
US20080311676A1 (en) 2008-12-18
ES2377167T3 (es) 2012-03-23
EP2174137A1 (de) 2010-04-14
US8288111B2 (en) 2012-10-16
JP5174898B2 (ja) 2013-04-03
CA2685830A1 (en) 2008-12-04
CA2685830C (en) 2012-12-18
WO2008147982A1 (en) 2008-12-04

Similar Documents

Publication Publication Date Title
ATE535813T1 (de) Reduzierte kreuzreaktivität mit hydrophoben arzneistoffanalyt-stoffwechselprodukten zeigende immuntestverfahren
EP3208617A3 (de) Lipidomische biomarker zur prognose kardiosvaskulärer ergebnisse bei patienten mit erkrankung der herzkranzgefässe ohne statinbehandlung
WO2013068374A3 (en) Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
MX2010006484A (es) Composiciones y metodos para detectar anticuerpos de infidelidad de transcripcion (tiab).
ES2500066T3 (es) Anticuerpos frente a ferroportina y métodos de uso
WO2010090471A3 (ko) 제1형 당뇨병의 신규한 진단 마커
SG10201408392PA (en) Methods of determining patient response by measurement of her-3
BR112013023006A2 (pt) formulações de suspensões não aquosas de anticorpos de alta concentração e viscosidade reduzida
AR053948A1 (es) Deteccion de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapeutico correspondiente
BRPI0906435B8 (pt) Anticorpo anti-cd79b quimérico, composto conjugado, formulação farmacêutica, método para determinar a presença da proteína cd79b, ensaio para detectar células de câncer, método para inibir proliferação celular, usos de um anticorpo, de um composto conjugado e de uma formulação farmacêutica, e método para a fabricação de um composto conjugado
EP3293522A3 (de) Lipidomik-biomarker zur identifizierung von patienten mit hohem risiko einer koronararterienerkrankung
WO2010051544A3 (en) Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
CL2009000090A1 (es) Anticuerpo que se une al receptor de tirosina quinasa b (trkb); composicion que comprende el anticuerpo; metodo para reducir los niveles de glucosa en la sangre y/o el peso corporal en un individuo.
NZ596659A (en) Bulbless spectrometer
BR112014014284A2 (pt) aparelho e método para detecção de partículas magnéticas em um campo de visão, e, programa de computador
WO2007024735A3 (en) Method and antibodies for detecting nitrofuran
NZ602840A (en) Immuno-pet imaging of antibodies and immunoconjugates and uses therefor
BR112012021590A2 (pt) detecção de capacitância em ensaio eletroquímico
EP2490025A3 (de) Verfahren, Anordnung und Verwendung davon
RU2013105265A (ru) Способ диагностики рака поджелудочной железы
EP2155185A4 (de) Nachweis von succinylaceton
SG170051A1 (en) T cell assays
WO2014001574A8 (en) Method for diagnosing invasive candida infections
GB201014837D0 (en) Biomarker signatures and uses thereof
MX2009012044A (es) Eliminacion de interferencia en inmunoensayos causada por anticuerpos anti-carbohidrato.